FIELD: medicine; ophthalmology.
SUBSTANCE: group of inventions relates to the field of medicine, namely to ophthalmology; it is intended for prevention or treatment of a pathological condition of corneal endothelium. A composition including rapamycin as a single active ingredient is used in prevention or treatment of Fuchs endothelial corneal dystrophy. The use of a composition including rapamycin for conservation and/or growth, or maintenance of growth of corneal endothelial cells is also presented.
EFFECT: use of the group of inventions provides prevention or treatment of Fuchs endothelial corneal dystrophy, as well as conservation and/or growth, or maintenance of growth of corneal endothelial cells.
4 cl, 21 dwg, 14 ex
